Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Astra Tech, Brånemark, and ITI Implants in the Rehabilitation of Partial Edentulism: Two-Year Results

Bilhan, Hakan DDS, PhD*; Kutay, Omer DDS, PhD; Arat, Selda DDS; Çekici, Ali DDS, PhD§; Cehreli, Murat Cavit DDS, PhD

doi: 10.1097/ID.0b013e3181f57110
Basic and Clinical Research
Buy

Purpose: To explore the soft tissue, marginal bone, and prosthetic complications (if any) of Astra Tech, Brånemark, and ITI implants supporting fixed prostheses during an observation period of 2 years.

Materials: The study comprised 26 patients, who received 42 Astra Tech, 36 Brånemark, and 29 ITI implants. After 3 months of healing, abutment connections were performed for Astra Tech and Brånemark implants, and fixed prostheses were delivered to the patients at 4 months. At 6-month, 1-year, and 2-year recall appointments, plaque index, periimplant inflammation index, and bleeding index scores, were recorded. The marginal bone levels were also measured at 2-year recall by means of radiographic evaluation, and prosthetic complications were recorded throughout the study.

Results: All implants survived during the 2-year observation period. The plaque index and periimplant inflammation index scores around Brånemark implants were higher than ITI and Astra Tech implants in the first year of function (P > 0.05). Marginal bone loss around ITI and Astra Tech implants was similar at 2 years (P > 0.05). The marginal bone loss around Brånemark implants was higher than Astra Tech implants (P < 0.05) but similar to ITI implants at 2-year recall appointment (P > 0.05). Fixed prostheses supported by ITI and Astra Tech implants did not experience prosthetic complications, and only 1 patient of the Brånemark group had porcelain veneer fracture.

Conclusions: Astra Tech, Brånemark, and ITI implants supporting fixed prostheses had same survival rates (100%) in this study. ITI and Astra Tech implants had similar changes in marginal bone levels, whereas Brånemark implants had higher marginal bone loss, particularly in the first year of function.

*Postdoctoral Research Assistant, Department of Removable Prosthodontics, Faculty of Dentistry, Istanbul University, Capa, Istanbul, Turkey.

†Professor, Department of Removable Prosthodontics, Faculty of Dentistry, Istanbul University, Capa, Istanbul, Turkey.

‡Research Assistant, Department of Removable Prosthodontics, Faculty of Dentistry, Istanbul University, Capa, Istanbul, Turkey.

§Postdoctoral Research Assistant, Department of Periodontology, Faculty of Dentistry, Istanbul University, Capa, Istanbul, Turkey.

∥Associate Professor, Section of Prosthodontics, CosmORAL Oral and Dental Health Polyclinics, Kavaklidere, Ankara, Turkey.

Reprint requests to and correspondence to: Murat Cehreli, DDS, PhD, Section of Prosthodontics, CosmORAL Oral and Dental Health Polyclinics, Cinnah Cad. 7/5 Kavaklidere, Ankara 06680, Turkey, Phone: 90.312.4661406, E-mail: mcehreli@hotmail.com

© 2010 Lippincott Williams & Wilkins, Inc.